vs
Side-by-side financial comparison of Norwegian Cruise Line Holdings (NCLH) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
Norwegian Cruise Line Holdings is the larger business by last-quarter revenue ($2.2B vs $1.4B, roughly 1.6× SELECT MEDICAL HOLDINGS CORP). SELECT MEDICAL HOLDINGS CORP runs the higher net margin — 1.4% vs 0.6%, a 0.8% gap on every dollar of revenue. On growth, SELECT MEDICAL HOLDINGS CORP posted the faster year-over-year revenue change (6.4% vs 6.4%). Norwegian Cruise Line Holdings produced more free cash flow last quarter ($21.5M vs $5.2M). Over the past eight quarters, SELECT MEDICAL HOLDINGS CORP's revenue compounded faster (2.8% CAGR vs 1.2%).
Norwegian Cruise Line (NCL) is an American cruise line founded in Norway in 1966, headquartered in Miami-Dade County, Florida, and incorporated in the Bahamas. It is the fourth-largest cruise line in the world by passengers, controlling about 8.6% of the total worldwide share of the cruise market by passengers as of 2021. It is wholly owned by parent company Norwegian Cruise Line Holdings.
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
NCLH vs SEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.2B | $1.4B |
| Net Profit | $14.3M | $20.2M |
| Gross Margin | 41.0% | — |
| Operating Margin | 8.3% | 4.6% |
| Net Margin | 0.6% | 1.4% |
| Revenue YoY | 6.4% | 6.4% |
| Net Profit YoY | -94.4% | 225.7% |
| EPS (diluted) | $0.08 | $0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.2B | $1.4B | ||
| Q3 25 | $2.9B | $1.4B | ||
| Q2 25 | $2.5B | $1.3B | ||
| Q1 25 | $2.1B | $1.4B | ||
| Q4 24 | $2.1B | $1.3B | ||
| Q3 24 | $2.8B | $1.3B | ||
| Q2 24 | $2.4B | $1.3B | ||
| Q1 24 | $2.2B | $1.3B |
| Q4 25 | $14.3M | $20.2M | ||
| Q3 25 | $419.3M | $28.8M | ||
| Q2 25 | $30.0M | $40.6M | ||
| Q1 25 | $-40.3M | $56.7M | ||
| Q4 24 | $254.5M | $-16.1M | ||
| Q3 24 | $474.9M | $55.6M | ||
| Q2 24 | $163.4M | $77.6M | ||
| Q1 24 | $17.4M | $96.9M |
| Q4 25 | 41.0% | — | ||
| Q3 25 | 47.1% | — | ||
| Q2 25 | 42.1% | — | ||
| Q1 25 | 38.7% | — | ||
| Q4 24 | 38.0% | — | ||
| Q3 24 | 45.2% | — | ||
| Q2 24 | 38.7% | — | ||
| Q1 24 | 36.7% | — |
| Q4 25 | 8.3% | 4.6% | ||
| Q3 25 | 25.5% | 5.4% | ||
| Q2 25 | 16.8% | 6.5% | ||
| Q1 25 | 9.4% | 8.3% | ||
| Q4 24 | 10.2% | 1.6% | ||
| Q3 24 | 24.6% | 4.3% | ||
| Q2 24 | 14.4% | 5.8% | ||
| Q1 24 | 10.0% | 9.0% |
| Q4 25 | 0.6% | 1.4% | ||
| Q3 25 | 14.3% | 2.1% | ||
| Q2 25 | 1.2% | 3.0% | ||
| Q1 25 | -1.9% | 4.2% | ||
| Q4 24 | 12.1% | -1.2% | ||
| Q3 24 | 16.9% | 4.4% | ||
| Q2 24 | 6.9% | 6.1% | ||
| Q1 24 | 0.8% | 7.3% |
| Q4 25 | $0.08 | $0.17 | ||
| Q3 25 | $0.86 | $0.23 | ||
| Q2 25 | $0.07 | $0.32 | ||
| Q1 25 | $-0.09 | $0.44 | ||
| Q4 24 | $0.55 | $-0.12 | ||
| Q3 24 | $0.95 | $0.43 | ||
| Q2 24 | $0.35 | $0.60 | ||
| Q1 24 | $0.04 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $209.9M | $26.5M |
| Total DebtLower is stronger | $13.7B | $1.8B |
| Stockholders' EquityBook value | $2.2B | $1.7B |
| Total Assets | $22.5B | $5.9B |
| Debt / EquityLower = less leverage | 6.21× | 1.06× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $209.9M | $26.5M | ||
| Q3 25 | $166.8M | $60.1M | ||
| Q2 25 | $184.0M | $52.3M | ||
| Q1 25 | $184.4M | $53.2M | ||
| Q4 24 | $190.8M | $59.7M | ||
| Q3 24 | $332.5M | $191.5M | ||
| Q2 24 | $594.1M | $111.2M | ||
| Q1 24 | $559.8M | $92.6M |
| Q4 25 | $13.7B | $1.8B | ||
| Q3 25 | $13.6B | $1.7B | ||
| Q2 25 | $12.6B | $1.8B | ||
| Q1 25 | $12.9B | $1.8B | ||
| Q4 24 | $11.8B | $1.7B | ||
| Q3 24 | $11.8B | $3.1B | ||
| Q2 24 | $11.9B | $3.6B | ||
| Q1 24 | $12.0B | $3.8B |
| Q4 25 | $2.2B | $1.7B | ||
| Q3 25 | $2.2B | $1.7B | ||
| Q2 25 | $1.6B | $1.7B | ||
| Q1 25 | $1.4B | $1.7B | ||
| Q4 24 | $1.4B | $1.7B | ||
| Q3 24 | $1.1B | $1.9B | ||
| Q2 24 | $693.1M | $1.4B | ||
| Q1 24 | $362.1M | $1.4B |
| Q4 25 | $22.5B | $5.9B | ||
| Q3 25 | $22.2B | $5.7B | ||
| Q2 25 | $21.6B | $5.7B | ||
| Q1 25 | $21.4B | $5.7B | ||
| Q4 24 | $20.0B | $5.6B | ||
| Q3 24 | $19.8B | $8.0B | ||
| Q2 24 | $20.1B | $7.9B | ||
| Q1 24 | $19.8B | $7.9B |
| Q4 25 | 6.21× | 1.06× | ||
| Q3 25 | 6.22× | 1.03× | ||
| Q2 25 | 8.05× | 1.10× | ||
| Q1 25 | 9.09× | 1.03× | ||
| Q4 24 | 8.26× | 1.01× | ||
| Q3 24 | 10.35× | 1.62× | ||
| Q2 24 | 17.19× | 2.54× | ||
| Q1 24 | 33.16× | 2.75× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $459.1M | $64.3M |
| Free Cash FlowOCF − Capex | $21.5M | $5.2M |
| FCF MarginFCF / Revenue | 1.0% | 0.4% |
| Capex IntensityCapex / Revenue | 19.5% | 4.2% |
| Cash ConversionOCF / Net Profit | 32.21× | 3.19× |
| TTM Free Cash FlowTrailing 4 quarters | $-1.2B | $117.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $459.1M | $64.3M | ||
| Q3 25 | $236.6M | $175.3M | ||
| Q2 25 | $714.9M | $110.3M | ||
| Q1 25 | $679.2M | $-3.5M | ||
| Q4 24 | $399.3M | $125.4M | ||
| Q3 24 | $172.5M | $181.0M | ||
| Q2 24 | $670.9M | $278.2M | ||
| Q1 24 | $807.2M | $-66.7M |
| Q4 25 | $21.5M | $5.2M | ||
| Q3 25 | $-726.5M | $122.2M | ||
| Q2 25 | $381.2M | $45.6M | ||
| Q1 25 | $-846.0M | $-55.8M | ||
| Q4 24 | $155.8M | $62.0M | ||
| Q3 24 | $-195.5M | $130.3M | ||
| Q2 24 | $330.2M | $222.6M | ||
| Q1 24 | $548.3M | $-119.2M |
| Q4 25 | 1.0% | 0.4% | ||
| Q3 25 | -24.7% | 9.0% | ||
| Q2 25 | 15.1% | 3.4% | ||
| Q1 25 | -39.8% | -4.1% | ||
| Q4 24 | 7.4% | 4.7% | ||
| Q3 24 | -7.0% | 10.2% | ||
| Q2 24 | 13.9% | 17.4% | ||
| Q1 24 | 25.0% | -9.0% |
| Q4 25 | 19.5% | 4.2% | ||
| Q3 25 | 32.8% | 3.9% | ||
| Q2 25 | 13.3% | 4.8% | ||
| Q1 25 | 71.7% | 3.9% | ||
| Q4 24 | 11.5% | 4.8% | ||
| Q3 24 | 13.1% | 4.0% | ||
| Q2 24 | 14.4% | 4.3% | ||
| Q1 24 | 11.8% | 4.0% |
| Q4 25 | 32.21× | 3.19× | ||
| Q3 25 | 0.56× | 6.09× | ||
| Q2 25 | 23.83× | 2.72× | ||
| Q1 25 | — | -0.06× | ||
| Q4 24 | 1.57× | — | ||
| Q3 24 | 0.36× | 3.25× | ||
| Q2 24 | 4.10× | 3.59× | ||
| Q1 24 | 46.51× | -0.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NCLH
| Passenger | $1.5B | 67% |
| Onboard And Other | $734.4M | 33% |
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
